Introduction.In recent years, one of the most current issues of modern obstetric and gynecological practice remains the problem of uterine leiomyoma in women of reproductive age. Nowadays, it occurs in 40.0-60.0 % of cases [8,12,13]. Consequently, the combination of pregnancy and this pathology has been increased by 20.0 %. The number of elderly primigravidas aged over 30 years has also a tendency to increase.According to numerous studies, the presence of uterine leiomyoma is associated with the high risk of obstetric and perinatal complications [4,[6][7][8][9][10]. A series of studies, both national and foreign authors, are dedicated to the search for modern treatment methods of this condition in pregnant women. Unfortunately, many issues remain unsolved and controversial, especially regarding the surgical treatment of pregnant women with the presence of indicated pathology; there are no generally accepted standards for pregnancy and delivery of these patients.Different degrees of developmental risk of obstetric and perinatal complications are determined by women's age exacerbated by hereditary, obstetric, gynecological and somatic anamnesis; localization, tumor size; severity of pathological changes in the uterus and systemic changes in the body caused by the development of tumor process [1,2,4,11].The complicated course of pregnancy in women with uterine leiomyoma occurs in approximately 10.0 to 40.0 % of cases [5,12]. Obstetric complications as threatened miscarriage, preterm labor, premature detachment of a normally located placenta, late gestosis, breech presentation and malposition may occur during pregnancy. There are also possible fetal complications: fetal growth retardation syndrome (FGRS), antenatal death, distress.The incidence of premature detachment of the normally located placenta and breech presentation in pregnant women with leiomyoma in the uterus is 4 times higher, bleeding in the first trimester of pregnancy is 2 times higher, the risk of Cesarean section is higher in 6 times, and the risk of antenatal fetal death increases in 2 times
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.